ACR Leaders Discuss Hydroxychloroquine Issues with FDA Commissioner
Guselkumab Approved for PsA
FDA Approves Secukinumab for Non-Radiographic Axial Spondyloarthritis
FDA Approves Tremfya (Guselkumab) for Adult Patients with Psoriatic Arthritis
FDA Approves Canakinumab for Adult-Onset Still’s Disease
FDA Approves Celecoxib in an Oral Solution
2 Pediatric Indications Sought for Golimumab
Baricitinib Studied as Possible COVID-19 Treatment; Plus Ranitidine Removed from U.S. Market
U.S. FDA Warns Against Using Hydroxychloroquine for COVID-19
- 1
- 2
- 3
- …
- 9
- Next Page »